Journal article
Pharmacogenetics in Cardiovascular Disease: The Challenge of Moving From Promise to Realization
Abstract
Pharmacogenetics in cardiovascular medicine brings the potential for personalized therapeutic strategies that improve efficacy and reduce harm. Studies evaluating the impact of genetic variation on pharmacologic effects have been undertaken for most major cardiovascular drugs, including antithrombotic agents, β-adrenergic receptor blockers, statins, and angiotensin-converting enzyme inhibitors. Across these drug classes, many polymorphisms …
Authors
Joseph PG; Pare G; Ross S; Roberts R; Anand SS
Journal
Clinical Cardiology, Vol. 37, No. 1, pp. 48–56
Publisher
Wiley
Publication Date
January 2014
DOI
10.1002/clc.22200
ISSN
0160-9289